Trial intelligence / Profile preview

Prednisone and rhTPO in Pregnant Women with Immune Thrombocytopenia

NCT05333744Phase 2Unknown

Sponsor
Peking University People's Hospital
Start
Jun 2021
Primary completion
Jun 2022
Modality
Cytokines & Interferons
Countries
1
01

Overview

A Phase 2 trial of recombinant human thrombopoietin in immune thrombocytopenia (ITP), sponsored by Peking University People's Hospital. Status: unknown.

02

Drugs

recombinant human thrombopoietin
03

Conditions

immune thrombocytopenia (ITP)

Beyond the preview

Go deeper on NCT05333744.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05333744.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call